The Medical Device Business Journal — Medical Device News & Articles | MassDevice
EndoChoice said it won a marketing license in Canada for its Fuse endoscopy system.
The Fuse endoscope features 3 small cameras that provide a 330-degree view, nearly double the range of typical colonoscopy devices.
The Fuse device won FDA 510(k) clearance in the U.S. in June 2013.
EndoChoice got the FDA’s green light for the Fuse endoscopy system, which the company says features numerous improvements over traditional endoscopy technology and will help docs catch more tumors.
The Alpharetta, Ga.-based colonoscopy device maker said its clinical trials demonstrated that Fuse only has a tumor "miss-rate" of 8%, compared with 42% with a traditional device.
Medical device companies pulled in more than $255 million from investors in 29 deals during January, according to data provided to MassDevice.com by CB Insights Inc.
The deals ranged widely in size, from a $25,000 seed round investment for Elyira, Ohio-based Guided Interventions and its passive coronary artery blockage sensing technology to a $43 million Series D round for EndoChoice and its endoscopes.
In a flurry of moves starting last week, medical device company EndoChoice pulled down a trifecta: A merger with Peer Medical, a $43 million funding round led by Sequoia Capital, and the acquisition of German endoscope maker RMS Endoskopie-Technik.
Alpharetta, Ga.-based EndoChoice said it plans to use the proceeds from the investment in the merged company to "finance projected growth." Some of that cash presumably went into the RMS deal, although no financial terms were disclosed.
Four medical device companies reeled in more than $70 million in recent weeks, to develop technologies including a laser scalpel for minimally invasive surgeries, a peripheral vessel stapler, a thermal ablation system and a biliary stent.
Cambridge, Mass.-based OmniGuide led the charge with a $35 million round from Orbimed Advisors. OmniGuide chairman Yoel Fink told MassDevice.com in 2010 that the device uses the mirror technology he pioneered at the Mass. Institute of Technology in the 1990s.
The foofaraw over St. Jude Medical‘s (NYSE:STJ) recalled Riata defibrillator leads is slated for top billing at the upcoming annual meeting of the Heart Rhythm Society in Boston, according to a pair of Leerink Swann analysts.
Private equity players are in for some stiff competition this year, as large-cap PE shops invade the middle-market space, according to a report from PE stalwart Bain & Co.
The company’s Global PE Report details a huge “exit overhang” – more aptly deemed an “exit hangover” by PE Hub’s Jonathan Marino – as PE-backed companies seek exits.
And the mega-deals of the past 10 years or so are a thing of the past, according the report, as detailed by Marino.
Argentum Medical is suing its former intellectual property law firm after it lost a patent infringement suit it filed against Noble Biomaterials.
Group purchasing organization goliath Premier health care alliance inked a new deal with EndoChoice Inc. for the Alpharetta, Ga.-based company’s gastrointestinal devices.
The deal gives Premier members access to special pricing and terms for EndoChoice’s gastroenterology products and supplies.
